Sadra Samavarchi Tehrani

1.2k total citations
49 papers, 922 citations indexed

About

Sadra Samavarchi Tehrani is a scholar working on Molecular Biology, Cancer Research and Epidemiology. According to data from OpenAlex, Sadra Samavarchi Tehrani has authored 49 papers receiving a total of 922 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 15 papers in Cancer Research and 9 papers in Epidemiology. Recurrent topics in Sadra Samavarchi Tehrani's work include Circular RNAs in diseases (14 papers), Cancer-related molecular mechanisms research (12 papers) and MicroRNA in disease regulation (8 papers). Sadra Samavarchi Tehrani is often cited by papers focused on Circular RNAs in diseases (14 papers), Cancer-related molecular mechanisms research (12 papers) and MicroRNA in disease regulation (8 papers). Sadra Samavarchi Tehrani collaborates with scholars based in Iran, Vietnam and Australia. Sadra Samavarchi Tehrani's co-authors include Mahmood Maniati, Ansar Karimian, Golnaz Goodarzi, Tooba Yousefi, Maryam Abbastabar, Khalil Azizian, Hadi Parsian, Bahman Yousefi, Maryam Majidinia and Ghodratollah Panahi and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Life Sciences.

In The Last Decade

Sadra Samavarchi Tehrani

49 papers receiving 914 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sadra Samavarchi Tehrani Iran 18 618 353 134 89 74 49 922
Fangfang Zhang China 19 726 1.2× 256 0.7× 131 1.0× 62 0.7× 65 0.9× 50 1.1k
Xiang Yu China 19 561 0.9× 243 0.7× 112 0.8× 58 0.7× 59 0.8× 51 837
Xu Yang China 16 541 0.9× 191 0.5× 110 0.8× 50 0.6× 61 0.8× 79 900
Hamiyet Dönmez‐Altuntaş Türkiye 19 386 0.6× 312 0.9× 76 0.6× 67 0.8× 89 1.2× 70 975
Wei Shao United States 14 532 0.9× 267 0.8× 84 0.6× 61 0.7× 78 1.1× 24 924
Dalia Ali Denmark 18 547 0.9× 219 0.6× 160 1.2× 156 1.8× 75 1.0× 38 1.2k
Junzheng Yang China 22 688 1.1× 237 0.7× 144 1.1× 44 0.5× 106 1.4× 67 1.1k
Qin Fu China 18 707 1.1× 381 1.1× 147 1.1× 30 0.3× 90 1.2× 28 997

Countries citing papers authored by Sadra Samavarchi Tehrani

Since Specialization
Citations

This map shows the geographic impact of Sadra Samavarchi Tehrani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sadra Samavarchi Tehrani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sadra Samavarchi Tehrani more than expected).

Fields of papers citing papers by Sadra Samavarchi Tehrani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sadra Samavarchi Tehrani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sadra Samavarchi Tehrani. The network helps show where Sadra Samavarchi Tehrani may publish in the future.

Co-authorship network of co-authors of Sadra Samavarchi Tehrani

This figure shows the co-authorship network connecting the top 25 collaborators of Sadra Samavarchi Tehrani. A scholar is included among the top collaborators of Sadra Samavarchi Tehrani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sadra Samavarchi Tehrani. Sadra Samavarchi Tehrani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Taheri, Maryam Akhavan, Ehsan Khalili, Ozra Tabatabaei‐Malazy, et al.. (2025). Therapeutic potential of fisetin in hepatic steatosis: Insights into autophagy pathway regulation and endoplasmic reticulum stress alleviation in high-fat diet-fed mice. PLoS ONE. 20(5). e0322335–e0322335. 1 indexed citations
2.
Tehrani, Sadra Samavarchi, Hamideh Mahmoodzadeh Hosseini, & Seyed Ali Mirhosseini. (2024). Evaluation of Anti-endotoxin Activity, Hemolytic Activity, and Cytotoxicity of a Novel Designed Peptide: An In Silico and In Vitro Study. International Journal of Peptide Research and Therapeutics. 30(2). 2 indexed citations
4.
Tehrani, Sadra Samavarchi, et al.. (2023). Combination therapy of metformin and morin attenuates insulin resistance, inflammation, and oxidative stress in skeletal muscle of high‐fat diet‐fed mice. Phytotherapy Research. 38(2). 912–924. 6 indexed citations
5.
6.
Goodarzi, Golnaz, Sadra Samavarchi Tehrani, Hemen Moradi‐Sardareh, et al.. (2023). Crosstalk between Alzheimer’s disease and diabetes: a focus on anti-diabetic drugs. Metabolic Brain Disease. 38(6). 1769–1800. 21 indexed citations
7.
Tehrani, Sadra Samavarchi, Moein Shirzad, Golnaz Goodarzi, et al.. (2023). The critical role of circular RNAs in drug resistance in gastrointestinal cancers. Medical Oncology. 40(4). 116–116. 4 indexed citations
8.
Shirzad, Moein, et al.. (2022). Critical involvement of circular RNAs in virus-associated cancers. Genes & Diseases. 10(6). 2296–2305. 9 indexed citations
9.
Tehrani, Sadra Samavarchi, et al.. (2021). Critical review of Epstein–Barr virus microRNAs relation with EBV‐associated gastric cancer. Journal of Cellular Physiology. 236(9). 6136–6153. 22 indexed citations
10.
Mir, Seyed Mostafa, Azadeh Aliarab, Golnaz Goodarzi, et al.. (2021). Melatonin: A smart molecule in the DNA repair system. Cell Biochemistry and Function. 40(1). 4–16. 19 indexed citations
11.
Ebrahimi, Mohsen, et al.. (2021). The critical role of mesenchymal stromal/stem cell therapy in COVID‐19 patients: An updated review. Cell Biochemistry and Function. 39(8). 945–954. 1 indexed citations
12.
Tehrani, Sadra Samavarchi, Ahmad Movahedpour, Golnaz Goodarzi, et al.. (2020). Design and evaluation of scFv-RTX-A as a novel immunotoxin for breast cancer treatment: an in silico approach. Journal of Immunoassay and Immunochemistry. 42(1). 19–33. 13 indexed citations
13.
Mir, Seyed Mostafa, et al.. (2020). The clinical significance of VDR and WIFI downregulation in colorectal cancer tissue. Gene Reports. 20. 100762–100762. 3 indexed citations
14.
Tehrani, Sadra Samavarchi, Tooba Yousefi, Ansar Karimian, et al.. (2020). Critical roles of long noncoding RNAs in breast cancer. Journal of Cellular Physiology. 235(6). 5059–5071. 45 indexed citations
15.
Tehrani, Sadra Samavarchi, Golnaz Goodarzi, Seyyed Hossein Khatami, et al.. (2020). Suitable Signal Peptides for Secretory Production of Recombinant Granulocyte Colony Stimulating Factor in Escherichia coli. Recent Patents on Biotechnology. 14(4). 269–282. 18 indexed citations
16.
Ebrahimi, Reyhane, Sadra Samavarchi Tehrani, Leila Setayesh, et al.. (2020). The genetic factors associated with Wnt signaling pathway in colorectal cancer. Life Sciences. 256. 118006–118006. 31 indexed citations
17.
Mir, Seyed Mostafa, Sadra Samavarchi Tehrani, Golnaz Goodarzi, et al.. (2020). <p>Shelterin Complex at Telomeres: Implications in Ageing</p>. Clinical Interventions in Aging. Volume 15. 827–839. 51 indexed citations
18.
Tehrani, Sadra Samavarchi, Tooba Yousefi, Ansar Karimian, et al.. (2019). MicroRNAs in breast cancer: Roles, functions, and mechanism of actions. Journal of Cellular Physiology. 235(6). 5008–5029. 75 indexed citations
19.
Ahmadpour‐Kacho, Mousa, et al.. (2019). Correlation between Prolonged Hyperbilirubinemia and Serum Zinc Level in Term Neonates. SHILAP Revista de lepidopterología. 10(4). 1–5. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026